David Berk
Corporate Officer/Principal bei ARCUTIS BIOTHERAPEUTICS, INC.
Profil
David Berk is currently the Vice President-Research & Development Strategy at Arcutis Biotherapeutics, Inc. He previously worked as the Executive Director & Head-Medical Dermatology at Allergan, Inc. from 2012 to 2018.
Prior to that, he was an Assistant Professor at Washington University in St. Louis from 2009 to 2012.
Dr. Berk holds a doctorate degree from Stanford University and an undergraduate degree from Princeton University.
Aktive Positionen von David Berk
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2019 |
Ehemalige bekannte Positionen von David Berk
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN, INC. | Director/Board Member | 01.12.2018 |
| Washington University in St. Louis | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von David Berk
| Stanford University | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
